A carregar...
Predicting Bevirimat resistance of HIV-1 from genotype
BACKGROUND: Maturation inhibitors are a new class of antiretroviral drugs. Bevirimat (BVM) was the first substance in this class of inhibitors entering clinical trials. While the inhibitory function of BVM is well established, the molecular mechanisms of action and resistance are not well understood...
Na minha lista:
Main Authors: | , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3224585/ https://ncbi.nlm.nih.gov/pubmed/20089140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2105-11-37 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|